-
ArcherDX, LLC et al v. QIAGEN Sciences, LLC et al DC CAFC
- 1:18-cv-01019
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/10/2018
- Closed: 08/08/2023
- Latest Docket Entry: 03/27/2024
- PACER
- Docket updated daily
2
Plaintiffs
9
Defendants
1
Accused
Product
2
Patents-in-Suit
1,856
Days in
Litigation
-
ArcherDX, LLC et al v. QIAGEN Sciences, LLC et al DC CAFC
- 1:18-cv-01019
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/10/2018
- Closed: 08/08/2023
- Latest Docket Entry: 03/27/2024
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
16 |
A method for preparing a nucleic acid for sequencing, the method comprising: (i) ligating a universal oligonucleotide tail adaptor that comprises a first ligatable duplex end and a second unpaired end to a nucleic acid comprising a known target
view more
|
Valid
Entry 551 Entry 482 Entry 465 |
17 |
The method ofclaim 16 further comprising, prior to step (i), phosphorylating the nucleic acid.
|
Valid
Entry 551 Entry 482 Entry 465 |
19 |
The method ofclaim 16, wherein ligating in step (i) comprises performing a TA ligation reaction.
|
Valid
Entry 551 Entry 482 Entry 465 |
-
Infringement
Jonathan Arnold
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 |
QIAGEN Beverly, LLC
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
QIAGEN Gaithersburg, LLC
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
Qiagen GmbH
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
Qiagen LLC
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
Qiagen NV
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
QIAGEN Sciences, LLC
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
GeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina platformQIAseq KitsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,017,810 B2 |
16, 17, 19
|
Willful infringement
Entry 551Entry 482 Entry 447 Entry 465 |
GeneRead QIAact KitsGeneRead QIAact RNAQIAseq Immune Repertoire RNA Library KitsQIAseq Index Kits for the Illumina and Ion Torrent platformsQIAseq Targeted DNA PanelsQIAseq Targeted RNAscan Panels | US 10,450,597 B2 |
1, 5, 19
|
Willful infringement
Entry 551Entry 482 Entry 465 |
-
Damages